ROCO:1294 (Taiwan)
Â
Ordinary Shares
NT$
56.6
+0.50 (+0.89%)
Jul 24
Business Description
Hantech Bio-Technology Co Ltd
ISIN : TW0001294007
Share Class Description:
ROCO:1294: Ordinary SharesTotal Employee Number:
102Compare
Compare
Traded in other countries / regions
1294.Taiwan IPO Date
2022-09-30Description
Hantech Bio-Technology Co Ltd mainly engaged in the manufacture, trading, and agency of biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.82 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | 0.42 | |||||
Interest Coverage | 58.3 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.45 | |||||
Beneish M-Score | -2.01 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 29.9 | |||||
3-Year EBITDA Growth Rate | 32.4 | |||||
3-Year EPS without NRI Growth Rate | 35.4 | |||||
3-Year Book Growth Rate | 41.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.15 | |||||
9-Day RSI | 33.38 | |||||
14-Day RSI | 32.91 | |||||
3-1 Month Momentum % | -0.5 | |||||
6-1 Month Momentum % | 3.91 | |||||
12-1 Month Momentum % | 16.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.4 | |||||
Quick Ratio | 1.96 | |||||
Cash Ratio | 1.38 | |||||
Days Inventory | 63.95 | |||||
Days Sales Outstanding | 47.94 | |||||
Days Payable | 60.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.3 | |||||
Dividend Payout Ratio | 0.65 | |||||
Forward Dividend Yield % | 5.3 | |||||
5-Year Yield-on-Cost % | 5.3 | |||||
3-Year Average Share Buyback Ratio | -3.4 | |||||
Shareholder Yield % | 13.5 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 37.11 | |||||
Operating Margin % | 22.29 | |||||
Net Margin % | 17.86 | |||||
EBITDA Margin % | 27.51 | |||||
FCF Margin % | 18.49 | |||||
OCF Margin % | 20.63 | |||||
ROE % | 17.12 | |||||
ROA % | 12.13 | |||||
ROIC % | 21.65 | |||||
3-Year ROIIC % | 32.8 | |||||
ROC (Joel Greenblatt) % | 31.16 | |||||
ROCE % | 19.37 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.47 | |||||
Forward PE Ratio | 10.33 | |||||
PE Ratio without NRI | 15.42 | |||||
PEG Ratio | 0.71 | |||||
PS Ratio | 2.76 | |||||
PB Ratio | 2.48 | |||||
Price-to-Tangible-Book | 2.49 | |||||
Price-to-Free-Cash-Flow | 15.08 | |||||
Price-to-Operating-Cash-Flow | 13.48 | |||||
EV-to-EBIT | 10.28 | |||||
EV-to-EBITDA | 8.45 | |||||
EV-to-Revenue | 2.32 | |||||
EV-to-FCF | 12.57 | |||||
Price-to-GF-Value | 0.73 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.68 | |||||
Price-to-Graham-Number | 1.31 | |||||
| Price-to-Net-Current-Asset-Value | 8.09 | |||||
| Price-to-Net-Cash | 943.33 | |||||
Earnings Yield (Greenblatt) % | 9.73 | |||||
FCF Yield % | 7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hantech Bio-Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 778.543 | ||
| EPS (TTM) (NT$) | 3.659 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.29 | ||
| 3-Year Sortino Ratio | 0.51 | ||
| Volatility % | 27.7 | ||
| 14-Day RSI | 32.91 | ||
| 14-Day ATR (NT$) | 1.351942 | ||
| 20-Day SMA (NT$) | 59.475833 | ||
| 12-1 Month Momentum % | 16.67 | ||
| 52-Week Range (NT$) | 55 - 80 | ||
| Shares Outstanding (Mil) | 36.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hantech Bio-Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hantech Bio-Technology Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 3.000000 Cash Dividend | 2026-07-03 | 66.25 (+0.89%) | ||
| 1.2:1 Stock Split | 2026-07-03 | 66.25 (+0.89%) | ||
| 1.10082:1 Stock Split | 2025-07-31 | 62.00 (+3.15%) | ||
| TWD 2.369439 Cash Dividend | 2025-07-15 | 55.64 (+0.00%) | ||
| 1.3:1 Stock Split | 2024-06-06 | 146.16 (-1.18%) | ||
| 1.15:1 Stock Split | 2023-07-07 | 63.30 (+7.76%) |
Show
Entries
Hantech Bio-Technology Co Ltd Frequently Asked Questions
What is Hantech Bio-Technology Co Ltd(ROCO:1294)'s stock price today?
The current price of ROCO:1294 is NT$56.60. The 52 week high of ROCO:1294 is NT$80.00 and 52 week low is NT$55.00.
When is next earnings date of Hantech Bio-Technology Co Ltd(ROCO:1294)?
The next earnings date of Hantech Bio-Technology Co Ltd(ROCO:1294) is .
Does Hantech Bio-Technology Co Ltd(ROCO:1294) pay dividends? If so, how much?
The Dividend Yield %  of Hantech Bio-Technology Co Ltd(ROCO:1294) is 5.3% (As of Today), Highest Dividend Payout Ratio of Hantech Bio-Technology Co Ltd(ROCO:1294) was 0.65. The lowest was 0.13. And the median was 0.13. The  Forward Dividend Yield % of Hantech Bio-Technology Co Ltd(ROCO:1294) is 5.3%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hantech Bio-Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers